Literature DB >> 8571966

The need for anonymous genetic counseling and testing.

M J Mehlman1, E D Kodish, P Whitehouse, A B Zinn, S Sollitto, J Berger, E J Chiao, M S Dosick, S B Cassidy.   

Abstract

Concerns are mounting about the risks of genetic discrimination resulting from the release of predictive and presymptomatic genetic test results to employers, insurers, and others. The ability to keep this information confidential is questionable, particularly in view of the expansion of electronic medical databases. One solution is to afford individuals access to anonymous genetic counseling and testing. Probands would be identified only by a code that would not reveal personal information, and test results would be stored, retrieved, and released solely on the basis of this code. The experience with anonymous HIV testing, while not completely analogous, suggests that such an approach would be both practical and effective.

Keywords:  Genetics and Reproduction; Professional Patient Relationship

Mesh:

Year:  1996        PMID: 8571966      PMCID: PMC1914541     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  5 in total

1.  Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease.

Authors:  A D Roses
Journal:  Ann Neurol       Date:  1995-07       Impact factor: 10.422

2.  Privacy and security of personal information in a new health care system.

Authors:  L O Gostin; J Turek-Brezina; M Powers; R Kozloff; R Faden; D D Steinauer
Journal:  JAMA       Date:  1993-11-24       Impact factor: 56.272

3.  Many people who seek anonymous HIV-antibody testing would avoid it under other circumstances.

Authors:  S M Kegeles; J A Catania; T J Coates; L M Pollack; B Lo
Journal:  AIDS       Date:  1990-06       Impact factor: 4.177

4.  Trial of anonymous versus confidential human immunodeficiency virus testing.

Authors:  L J Fehrs; D Fleming; L R Foster; R O McAlister; V Fox; S Modesitt; R Conrad
Journal:  Lancet       Date:  1988-08-13       Impact factor: 79.321

5.  Genetic testing for children and adolescents. Who decides?

Authors:  D C Wertz; J H Fanos; P R Reilly
Journal:  JAMA       Date:  1994-09-21       Impact factor: 56.272

  5 in total
  10 in total

1.  Alzheimer's Disease.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-01       Impact factor: 3.598

2.  Letting the family know: balancing ethics and effectiveness when notifying relatives about genetic testing for a familial disorder.

Authors:  G K Suthers; J Armstrong; J McCormack; D Trott
Journal:  J Med Genet       Date:  2005-12-21       Impact factor: 6.318

3.  Anonymous genetic testing: reply to Mehlman et al.

Authors:  E W Clayton; M A Rothstein
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

4.  Questioning the need for anonymous genetic counseling and testing.

Authors:  W R Uhlmann; D Ginsburg; T D Gelehrter; J Nicholson; E M Petty
Journal:  Am J Hum Genet       Date:  1996-10       Impact factor: 11.025

5.  Efficacy of a targeted genetic screening program for adolescents.

Authors:  L McCabe
Journal:  Am J Hum Genet       Date:  1996-10       Impact factor: 11.025

Review 6.  Insurance underwriting in the genetic era.

Authors:  R J Pokorski
Journal:  Am J Hum Genet       Date:  1997-01       Impact factor: 11.025

Review 7.  Ethical issues in neurogenetics.

Authors:  Wendy R Uhlmann; J Scott Roberts
Journal:  Handb Clin Neurol       Date:  2018

8.  Nonparticipation in Huntington's Disease Predictive Testing: Reasons for Caution in Interpreting Findings.

Authors:  J Binedell; J R Soldan
Journal:  J Genet Couns       Date:  1997-12       Impact factor: 2.537

9.  Attitudes and practice of genetic counselors regarding anonymous testing for BRCA1/2.

Authors:  Tammy Ader; Lisa R Susswein; Nancy P Callanan; James P Evans
Journal:  J Genet Couns       Date:  2009-10-02       Impact factor: 2.537

10.  Alzheimer's disease.

Authors:  A S Schachter; K L Davis
Journal:  Dialogues Clin Neurosci       Date:  2000-06       Impact factor: 5.986

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.